Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie B Spangler

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
ACS Nano|March 24, 2022
Suspendable Hydrogel Nanovials for Massively Parallel Single-Cell Functional Analysis and SortingJoseph de Rutte, Robert Dimatteo, Maani M Archang, et al.
JCI Insight|August 8, 2024
Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.
Cell|June 27, 2024
Preclinical proof of principle for orally delivered Th17 antagonist miniproteinsStephanie Berger, Franziska Seeger, Ta-Yi Yu, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 15, 2024
In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node MatrixNatalie K Livingston, John W Hickey, Hajin Sim, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy targetZhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Cell Reports|October 19, 2022
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protectionDerek VanDyke, Marcos Iglesias, Jakub Tomala, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2020
IgM autoantibodies recognizing ACE2 are associated with severe COVID-19Livia Casciola-Rosen, David R Thiemann, Felipe Andrade, et al.
Nature|January 11, 2019
De novo design of potent and selective mimics of IL-2 and IL-15Daniel-Adriano Silva, Shawn Yu, Umut Y Ulge, et al.
Nature Chemical Biology|April 6, 2023
Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffoldsHuilin Yang, Umut Y Ulge, Alfredo Quijano-Rubio, et al.
Cell Reports|August 9, 2025
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomasPriyanka Sehgal, Ammar S Naqvi, Makenna Higgins, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
ACS Nano|March 24, 2022
Suspendable Hydrogel Nanovials for Massively Parallel Single-Cell Functional Analysis and SortingJoseph de Rutte, Robert Dimatteo, Maani M Archang, et al.
JCI Insight|August 8, 2024
Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activityElissa K Leonard, Jakub Tomala, Joseph R Gould, et al.
Cell|June 27, 2024
Preclinical proof of principle for orally delivered Th17 antagonist miniproteinsStephanie Berger, Franziska Seeger, Ta-Yi Yu, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 15, 2024
In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node MatrixNatalie K Livingston, John W Hickey, Hajin Sim, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy targetZhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Cell Reports|October 19, 2022
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protectionDerek VanDyke, Marcos Iglesias, Jakub Tomala, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2020
IgM autoantibodies recognizing ACE2 are associated with severe COVID-19Livia Casciola-Rosen, David R Thiemann, Felipe Andrade, et al.
Nature|January 11, 2019
De novo design of potent and selective mimics of IL-2 and IL-15Daniel-Adriano Silva, Shawn Yu, Umut Y Ulge, et al.
Nature Chemical Biology|April 6, 2023
Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffoldsHuilin Yang, Umut Y Ulge, Alfredo Quijano-Rubio, et al.
Cell Reports|August 9, 2025
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomasPriyanka Sehgal, Ammar S Naqvi, Makenna Higgins, et al.
Pageof 9